Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Efficacy and Safety of Meloxicam Injection for Postoperative Analgesia in Abdominal Surgery Patients: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Clinical Trial

NCT06904248 is registered in ClinicalTrials.gov with Yangtze River Pharmaceutical Group Co., Ltd. as lead sponsor.

NCT NCT06904248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06904248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Efficacy and Safety of Meloxicam Injection for Postoperative Analgesia in Abdominal Surgery Patients: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Clinical Trial
Lead sponsor
Yangtze River Pharmaceutical Group Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
January 29, 2024
Completion date
February 10, 2025
Enrollment
224 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

participants with acute moderate to severe pain following abdominal surgery